AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal 2023
January 13, 2023 at 01:00 am EST
Share
AFC-HD AMS Life Science Co., Ltd. provided dividend guidance for the second quarter and year end of fiscal 2023. The company expected dividend of JPY 12.50 per share compared to JPY 15.00 per share paid a year ago.
For the year end of 2023, the company expected dividend Of JPY 12.50 per share compared to JPY 15.00 per share paid a year ago.
AFC-HD AMS Life Science Co Ltd is a Japan-based company mainly engaged in the development of the healthcare business and the pharmaceutical business. The Company is engaged in the research and development, product design, manufacture and sale of health foods and cosmetics, manufacture and sale of Chinese medicine medicines, general medicines, generic medicines, healthcare products, the sale of natural foods, as well as planning of health information programs. The Company operates in two business segments. The Healthcare segment is engaged in the manufacture and sale of health foods and cosmetics, as well as the provision of original equipment manufacturers (OEM). The Pharmaceutical segment is engaged in the manufacture and sale of ethical drugs and over-the-counter drugs, as well as the sale of generic drugs. The Company is also engaged in the management of restaurants through subsidiary.